Article Information
- Received May 2, 2016
- Revision received August 26, 2016
- Accepted September 8, 2016
- Published online October 19, 2016.
Author Information
- Silvina Catuara-Solarz1,2,3,
- Jose Espinosa-Carrasco1,2,4,
- Ionas Erb2,4,
- Klaus Langohr3,5,
- Juan Ramon Gonzalez6,7,
- Cedric Notredame2,4 and
- Mara Dierssen1,3,8
- 1Cellular and Systems Neurobiology, Systems Biology Program, the Barcelona Institute of Science and Technology, Centre for Genomic Regulation (CRG), 08003, Barcelona, Spain
- 2Universitat Pompeu Fabra (UPF), Barcelona, 08003, Spain
- 3Human Pharmacology and Clinical Neurosciences Research Group, Neurosciences Research Program, Hospital Del Mar Medical Research Institute (IMIM), Barcelona, 08003, Spain
- 4Comparative Bioinformatics, Bioinformatics, and Genomics Program, Barcelona Institute of Science and Technology, Centre for Genomic Regulation, Barcelona, 08003, Spain
- 5Department of Statistics and Operations Research, Universitat Politècnica De Catalunya/BarcelonaTech, Barcelona, 08034, Spain
- 6Centre for Research in Environmental Epidemiology, Barcelona, 08003, Spain
- 7Centro De Investigación Biomédica En Red De Epidemiología Y Salud Pública, Madrid, 28029, Spain
- 8Centro De Investigación Biomédica En Red De Enfermedades Raras, Madrid, 28029, Spain
- Correspondence should be addressed to M. Dierssen, Cellular and Systems Neurobiology, Systems Biology Program, Centre for Genomic Regulation, Dr. Aiguader 88, 08003 Barcelona, Spain. E-mail: mara.dierssen{at}crg.eu.
Author contributions
Disclosures
Authors report no conflict of interest.
Authors Contribution: S.C.S. designed research, performed research, analyzed data, wrote the paper; J.E.-C., I.E., K.L., J.R.G. analyzed data; C.N. supervised the PCA analysis; M.D. provided financial support, designed research, wrote the paper.
This research was supported by DIUE of Generalitat de Catalunya (Grups consolidats SGR 2014/1125); Fondation Jérôme Lejeune (Paris, France); Spanish Ministry of Economy and Finance (MINECO) grants SAF2013-49129-C2-1-R, BFU2011-28575, and MTM2015-64465-C2-1-R CDTI (“Smartfoods”); the CIBER of Rare Diseases (ISCIII initiative); and EU-Era Net Neuron PCIN-2013-060. The CRG has received support as a Severo Ochoa Center of Excellence SEV- 2012-O208. S.C.-S. received a FPI doctoral Fellowship from the MINECO (SAF2010-16427).
Funding
MINECO | Consejo Superior de Investigaciones Científicas (CSIC)
501100003339; SAF2013-49129-C2-1-RDIUE of Generalitat de Catalunya (Grups consolidats)
SGR 2014/1125Fondation Jérôme Lejeune
N.ACDTI Smartfoods, CIBER of Rare Disease ISCIII initiave
N.A.EU-Era Net Neuron
PCIN-2013- 060Severo Ochoa Center of Excellence
SEV- 2012-0208
Other Version
- previous version (October 19, 2016).
- You are viewing the most recent version of this article.
Online Impact
Article usage
In this issue
